1. Lukacova, Eva, Burjanivova, Tatiana, Podlesniy, Petar, Mersakova, Sandra, Lasabova, Zora. 2023. Hypermethylated GRIA4, a potential biomarker for an early non-invasive detection of metastasis of clinically known colorectal cancer. In Frontiers in oncology, 13, 1205791. doi:10.3389/fonc.2023.1205791. https://pubmed.ncbi.nlm.nih.gov/37476382/
2. Wang, Hua, Liu, Jiatong, Li, Fuwei, Liu, Mingyu, Gu, Weiyue. 2022. Novel Heterozygous Missense Variant in GRIA4 Gene Associated With Neurodevelopmental Disorder With or Without Seizures and Gait Abnormalities. In Frontiers in genetics, 13, 859140. doi:10.3389/fgene.2022.859140. https://pubmed.ncbi.nlm.nih.gov/35518358/
3. Hauptman, Nina, Jevšinek Skok, Daša, Spasovska, Elena, Boštjančič, Emanuela, Glavač, Damjan. 2019. Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer. In BMC medical genomics, 12, 54. doi:10.1186/s12920-019-0501-z. https://pubmed.ncbi.nlm.nih.gov/30987631/
4. Martin, Sonja, Chamberlin, Adam, Shinde, Deepali N, Lessel, Davor, Abou Jamra, Rami. . De Novo Variants in GRIA4 Lead to Intellectual Disability with or without Seizures and Gait Abnormalities. In American journal of human genetics, 101, 1013-1020. doi:10.1016/j.ajhg.2017.11.004. https://pubmed.ncbi.nlm.nih.gov/29220673/
5. Beyer, Barbara, Deleuze, Charlotte, Letts, Verity A, Huguenard, John R, Frankel, Wayne N. 2008. Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4. In Human molecular genetics, 17, 1738-49. doi:10.1093/hmg/ddn064. https://pubmed.ncbi.nlm.nih.gov/18316356/